| Secondary |
| Drug Use For Unknown Indication |
24.3% |
| Product Used For Unknown Indication |
14.2% |
| Prophylaxis |
9.7% |
| Cord Blood Transplant Therapy |
7.5% |
| Cytomegalovirus Infection |
7.5% |
| Hypertension |
3.7% |
| Hypothyroidism |
3.0% |
| Insomnia |
3.0% |
| Prevention |
3.0% |
| Cholestasis |
2.6% |
| Depression |
2.6% |
| Immunosuppression |
2.6% |
| Aspergillus Infection |
2.2% |
| Oedema Peripheral |
2.2% |
| Sedation |
2.2% |
| Anxiety |
1.9% |
| Bone Marrow Transplant |
1.9% |
| Diarrhoea |
1.9% |
| Plasma Cell Myeloma |
1.9% |
| Vitamin B12 Deficiency |
1.9% |
|
| Thrombotic Microangiopathy |
14.6% |
| Hyperlactacidaemia |
7.3% |
| Quadriparesis |
7.3% |
| Splenic Infarction |
7.3% |
| Thrombocytopenia |
7.3% |
| Toxic Skin Eruption |
7.3% |
| Haemolytic Anaemia |
4.9% |
| Intravascular Haemolysis |
4.9% |
| Memory Impairment |
4.9% |
| Pain In Extremity |
4.9% |
| Rash Maculo-papular |
4.9% |
| Thrombocytopenic Purpura |
4.9% |
| Aplastic Anaemia |
2.4% |
| Clostridial Infection |
2.4% |
| Colitis Ulcerative |
2.4% |
| Diarrhoea |
2.4% |
| Febrile Neutropenia |
2.4% |
| Gastrointestinal Haemorrhage |
2.4% |
| Hepatic Enzyme Increased |
2.4% |
| Iatrogenic Injury |
2.4% |
|
| Concomitant |
| Product Used For Unknown Indication |
24.2% |
| Drug Use For Unknown Indication |
23.2% |
| Prophylaxis |
7.0% |
| Plasma Cell Myeloma |
5.8% |
| Infection Prophylaxis |
5.1% |
| Hypertension |
4.2% |
| Multiple Myeloma |
4.0% |
| Chronic Graft Versus Host Disease |
3.2% |
| Pain |
3.0% |
| Thrombosis Prophylaxis |
2.7% |
| Pyrexia |
2.1% |
| Diabetes Mellitus |
1.9% |
| Haemolytic Uraemic Syndrome |
1.9% |
| Hiv Test Positive |
1.9% |
| Bone Pain |
1.8% |
| Chemotherapy |
1.8% |
| Dyspepsia |
1.8% |
| Hepatitis C |
1.6% |
| Epilepsy |
1.4% |
| Hiv Infection |
1.4% |
|
| Vomiting |
10.8% |
| Septic Shock |
8.4% |
| Renal Vein Thrombosis |
7.2% |
| Toxic Skin Eruption |
7.2% |
| Intravascular Haemolysis |
6.0% |
| Weight Decreased |
6.0% |
| Pyrexia |
4.8% |
| Thrombocytopenia |
4.8% |
| Thrombotic Thrombocytopenic Purpura |
4.8% |
| Eosinophilia |
3.6% |
| Epilepsy |
3.6% |
| Gastrointestinal Necrosis |
3.6% |
| Haemolysis |
3.6% |
| Kaposi's Sarcoma |
3.6% |
| Lung Disorder |
3.6% |
| Palmar-plantar Erythrodysaesthesia Syndrome |
3.6% |
| Pancytopenia |
3.6% |
| Posterior Reversible Encephalopathy Syndrome |
3.6% |
| Renal Failure |
3.6% |
| Renal Failure Acute |
3.6% |
|
| Interacting |
| Hypertension |
40.0% |
| Depression |
20.0% |
| Hypothyroidism |
20.0% |
| Parkinson's Disease |
20.0% |
|
|
